NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

CUSIP: 64125C109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
99,963,154
Total 13F shares
94,376,685
Share change
+1,413,870
Total reported value
$12,879,887,685
Put/Call ratio
94%
Price per share
$136.50
Number of holders
596
Value change
+$230,192,847
Number of buys
292
Number of sells
281

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
14%
14,256,048
$1,642,581,850 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
10%
9,996,960
$1,151,849,731 30 Sep 2024
13F
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.8%
from 13D/G
5,148,293
$593,186,319 30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.6%
2,574,546
$296,639,190 30 Sep 2024
13F
Bellevue Group AG
13F
Company
1.9%
1,863,800
$214,747,036 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
1,859,232
$213,772,686 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.8%
1,843,281
$212,198,509 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.8%
1,764,590
$203,316,060 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.7%
1,675,176
$193,015,000 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.5%
1,497,931
$172,591,610 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.3%
1,349,381
$155,476,146 30 Sep 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.3%
1,316,590
$151,697,500 30 Sep 2024
13F
DODGE & COX
13F
Company
1.3%
1,287,820
$148,382,620 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1%
1,017,154
$117,196,523 30 Sep 2024
13F
DSM CAPITAL PARTNERS LLC
13F
Company
0.94%
944,154
$108,785,424 30 Sep 2024
13F
BROWN ADVISORY INC
13F
Company
0.94%
942,147
$108,554,177 30 Sep 2024
13F
Rock Springs Capital Management LP
13F
Company
0.94%
939,000
$108,191,580 30 Sep 2024
13F
BRAIDWELL LP
13F
Company
0.92%
917,674
$105,734,398 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.89%
894,217
$103,031,682 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.87%
874,665
$100,778,957 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.86%
858,250
$98,887,622 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.84%
842,197
$97,029,587 30 Sep 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.82%
819,968
$94,478,000 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.79%
792,196
$91,275,517 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.77%
771,624
$88,906,517 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.76%
763,355
$87,953,763 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.75%
747,291
$86,102,868 30 Sep 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
0.74%
736,910
$84,906,769 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.72%
718,226
$82,754,000 30 Sep 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.69%
689,986
$79,500,240 30 Sep 2024
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.62%
621,363
$78,130,183 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.66%
664,336
$77,355,284 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.64%
636,914
$73,385,231 30 Sep 2024
13F
Amundi
13F
Individual
0.66%
656,695
$73,326,563 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.62%
623,588
$71,849,789 30 Sep 2024
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
0.58%
582,789
$67,148,949 30 Sep 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.54%
544,321
$62,716,660 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.53%
533,324
$61,449,591 30 Sep 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.52%
524,168
$60,394,637 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.52%
523,632
$60,330,814 30 Sep 2024
13F
Fiera Capital Corp
13F
Company
0.52%
516,801
$59,545,811 30 Sep 2024
13F
IEQ CAPITAL, LLC
13F
Company
0.51%
512,480
$59,047,945 30 Sep 2024
13F
GW&K Investment Management, LLC
13F
Company
0.51%
510,089
$58,772,000 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.5%
496,094
$57,159,954 30 Sep 2024
13F
MACQUARIE GROUP LTD
13F
Company
0.49%
492,190
$56,710,127 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
0.48%
483,241
$55,676,534 30 Sep 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.46%
462,147
$53,248,577 30 Sep 2024
13F
Avidity Partners Management LP
13F
Company
0.46%
460,000
$53,001,200 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.44%
437,831
$50,446,888 30 Sep 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.42%
420,748
$48,478,585 30 Sep 2024
13F

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2024

As of 31 Dec 2024, NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by 596 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 94,376,685 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Dodge & Cox, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Bellevue Group AG, and MORGAN STANLEY. This page lists 600 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
570
Q4 2024 holders
596
Holder diff
26
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .